Palvella Therapeutics, Inc.
NASDAQPalvella Therapeutics enters the week with a sharp split between options sentiment and short positioning — calls dominating the tape while nearly a fifth of the float remains borrowed against the stock. The most striking signal is in options. Investors have rarely been this bullish on PVLA through derivatives: the put/call ratio has collapsed to 0.18, almost two full standard…
Snapshot as of 21 May 2026
Palvella Therapeutics enters the week with a sharp split between options sentiment and short positioning — calls dominating the tape while nearly a fifth of the float remains borrowed against the stock. The most…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PVLA — free to start on ORTEX.
Sign up for free →Open PVLA on ORTEX